Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zilun Hu

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
ISA Transactions|August 7, 2025
Distributed real-time dynamic cooperative optimization with unknown performance function form under resources constraintsZilun Hu, Chao Ni
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Glycine alpha-ketoamides as HCV NS3 protease inhibitorsWei Han, Zilun Hu, Xiangjun Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
Investigation of glycine alpha-ketoamide HCV NS3 protease inhibitors: effect of carboxylic acid isosteresWei Han, Xiangjun Jiang, Zilun Hu, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2023
Phthalazinone-based lactams and cyclic ureas as ROCK2 selective inhibitorsZilun Hu, Doree Sitkoff, Peter W Glunz, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Identification of 5H-chromeno[3,4-c]pyridine and 6H-isochromeno[3,4-c]pyridine derivatives as potent and selective dual ROCK inhibitorsZilun Hu, Cailan Wang, Doree Sitkoff, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2018
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitorsZilun Hu, Cailan Wang, Wei Han, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agentsZilun Hu, Xiangjun Jiang, Charles F Albright, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2008
Sulfonamidolactam inhibitors of coagulation factor XaJoanne M Smallheer, Shuaige Wang, Mia L Laws, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2007
Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' MoietyZilun Hu, Pancras C Wong, Paul J Gilligan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
ISA Transactions|August 7, 2025
Distributed real-time dynamic cooperative optimization with unknown performance function form under resources constraintsZilun Hu, Chao Ni
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Glycine alpha-ketoamides as HCV NS3 protease inhibitorsWei Han, Zilun Hu, Xiangjun Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
Investigation of glycine alpha-ketoamide HCV NS3 protease inhibitors: effect of carboxylic acid isosteresWei Han, Xiangjun Jiang, Zilun Hu, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2023
Phthalazinone-based lactams and cyclic ureas as ROCK2 selective inhibitorsZilun Hu, Doree Sitkoff, Peter W Glunz, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Identification of 5H-chromeno[3,4-c]pyridine and 6H-isochromeno[3,4-c]pyridine derivatives as potent and selective dual ROCK inhibitorsZilun Hu, Cailan Wang, Doree Sitkoff, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2018
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitorsZilun Hu, Cailan Wang, Wei Han, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agentsZilun Hu, Xiangjun Jiang, Charles F Albright, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2008
Sulfonamidolactam inhibitors of coagulation factor XaJoanne M Smallheer, Shuaige Wang, Mia L Laws, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2007
Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' MoietyZilun Hu, Pancras C Wong, Paul J Gilligan, et al.
Pageof 2